Enabling Personalized Medicine in clinical care to improve health profiles in diverse communities is a top priority in the strategic plan of The Icahn School of Medicine at Mount Sinai. Mount Sinai serves diverse communities of New York City with broad health disparities. Mount Sinai Medical Center and the Institute for Personalized Medicine (IPM) are committed to share these unique resources to advance genomic medicine, as a member of the eMERGE II Network and to advance the clinical translation of genomic knowledge to reduce health disparities and improve health outcomes in diverse communities. IPM looks to provide investigators with greater and easier access to high quality standardized data linked with longitudinal clinical information, and with technology support for discovering clinically important genotype-phenotype associations. IPM facilitates clinical development of gene-based diagnostics and risk assessment algorithms and evaluates their impact on health care delivery at the patient and population level.
Marshfield Clinic is preparing its clinical systems for meaningful use, accountable care and patient centered home care. Because of this, the EHR development and systems are being redesigned to focus on delivering services that will interact with decision support engines and clinical databases to drive changes to support additional data collection and medical decision-making.
Geisinger Health System (GHS) is an integrated, comprehensive health care delivery system that serves a large, stable, mainly rural population in north central and northeastern Pennsylvania. Geisinger has a fully functional and integrated electronic medical record (EMR) system, and is a recognized leader in the use of EMR and health information technology. GHS has received national accolades for its commitment to developing and testing information technology-enabled innovations in health care delivery. Geisinger’s infrastructure and experience in this area provide a paradigm for incorporating genomic data into clinical care.
Marc S. Williams, MD
David J. Carey, PhD
Dean Parry, RPh
About: Individualized medicine is one of Mayo Clinic’s foremost strategic priorities. The Mayo Center for Individualized Medicine is an institution-wide strategic initiative that includes comprehensive, accurate and accessible clinical data; support for robust biobanks of annotated biospecimens; laboratories charged with biomarker discover and development; state-of-the-art technologies for data sourcing; enterprise infrastructure for high throughput data transport and management; robust analytic and interpretive computational tools and expertise in translation of data into applicable clinical tools; and effective clinical implementation by divisions, departments and centers in Mayo Clinic. Other efforts include the creation of risk communication tools, implementation into the EMR, and a randomized trial investigating patient responses to genotype informed risk.
This is the content for Albert Einstein College of Medicine (partnering with Montefiore Medical Center).